Metered-dose inhalers: Actuators old and new

Expert Opinion on Drug Delivery

Volumn 4, Issue 3, 2007, Pages 235-245

  Lewis, David ^a  

^a VECTURA GROUP PLC   (United Kingdom)

Author keywords

Actuator design; Hydrofluoroalkane; Metered dose inhaler

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; INSULIN; PROPELLANT; SALBUTAMOL; SALBUTAMOL SULFATE;

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRY POWDER; HUMAN; INHALATION SPACER; INSULIN DEPENDENT DIABETES MELLITUS; METERED DOSE INHALER; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; POWDER INHALER; REVIEW; SAFETY;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; METERED DOSE INHALERS;

EID: 34248652945     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.4.3.235     Document Type: Review

References (90)

1. BROCKLEBANK D, RAM F, WRIGHT J et al.: Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol. Assess. (2001) 5(26):1-149.
2. THIEL CG: From Susie's question to CFC free: an inventor's perspective on 40 years of MDI development and regulation. Proceedings of Respiratory Drug Delivery V. Phoenix, AZ, USA (1996):115-124.
3. FREEDMAN T: Medihaler therapy for bronchial asthma: a new type of aerosol therapy. Postgrad. Med. (1956) 12:667-673.
4. RAU JL: The inhalation of drugs: advantages and problems. Respir. Care (2005) 50(3):367-382.
5. NEWMAN SP, NEWHOUSE MT: Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J. Aerosol Med. (1996) 9(1):55-70.
6. NEWMAN SP: Principles of metered-dose inhaler design. Respir. Care (2005) 50(9):1177-1190.
7. RICHARDS J, HIRST P, PITCAIRN G et al.: Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. J. Aerosol Med. (2001) 14(2):197-208.
8. VERSTEEG HK, HARGRAVE G: Fundamentals and resilience of the original MDI actuator design. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 1:91-100.
9. EVERARD ML: Aerosol therapy past, present, and future: a clinician's perspective. Respir. Care (2000) 45(6):769-776.
10. RAU JL: Practical problems with aerosol therapy in COPD. Respir. Care (2006) 51(2):158-172.
11. VAN BEERENDONK I, MESTERS I, MUDDE AN, TAN TD: Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J. Asthma (1998) 35(3):273-279.
12. HENDELES L, HATTON RC, COONS TJ, CARLSON L: Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber. Am. J. Health Syst. Pharm. (2005) 62:1053-1061.
13. GROSSMAN J: The evolution of inhaler technology. J. Asthma (1994) 31(1):55-64.
14. GUNAWARDENA KA, SOHAL T, JONES JI, UPCHURCH FC, CROMPTON GK: The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device. Respir. Med. (1997) 91(5):311-316.
15. CROMPTON GK: Problems patients have using pressurized aerosol inhalers. Eur. J. Respir. Dis. Suppl. (1982) 119:101-104.
16. SONG WS, MULLON J, REGAN NA, ROTH BJ: Instruction of hospitalized patients by respiratory therapists on metered-dose inhaler use leads to decrease in patient errors. Respir. Care (2005) 50(8):1040-1045.
17. BLOOMFIELD P, CROMPTON GK, WINSEY NJ: A tube spacer to improve inhalation of drugs from pressurised aerosols. Br. Med. J. (1979) 2(6203):1479.
18. LEWIS DA, MEAKIN BJ, BRAMBILLA G: New actuators versus old: reasons and results for actuator modifications for HFA solution MDIs. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 1:101-110.
19. LOUCA E, LEUNG K, COATES AL, MITCHELL JP, NAGEL MW: Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model. J. Aerosol Med. (2006) 19(2):160-167.
20. DUBUS JC, DOLOVICH M: Emitted doses of salbutamol pressurized metered-dose inhaler from five different plastic spacer devices. Fundam. Clin. Pharmacol. (2000) 14(3):219-224.
21. LEE H, EVANS HE: Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest (1987) 91(3):366-369.
22. KISSOON N, TEELUCKSINGH S, BLAKE KV, KESSER B, MURPHY SP, GELLER D: Plastic bottles as spacers for a pressurized metered-dose inhaler: in vitro characteristics. West Indian Med. J. (2001) 50(3):189-193.
23. OBGANDZE TN, NEMSADZE KP, CHKHAIDZE IG, PERADZE DI: Effectiveness of treatment of bronchoobstruction in children with acute respiratory infections using home-made spacer. Georgian Med. News (2005) 118:46-49.
24. SINGHAL T, GARG H, ARORA HS, LODHA R, PANDEY RM, KABRA SK: Efficacy of a home-made spacer with acute exacerbation of bronchial asthma: a randomized controlled trial. Indian J. Pediatr. (2001) 68(1):37-40.
25. SAMARANAYAKE SW, PERERA BJ: Paper spacers coupled to metered dose inhalers in family practice. Ceylon Med. J. (1998) 43(3):147-150.
26. ZAR H, STREUN S, LEVIN M, WEINBERG E, SWINGLER G: Randomised controlled trial of the efficacy of a metered dose inhaler with bottle spacer for bronchodilator therapy in acute lower airways obstruction. Arch. Dis. Child. (2006) (In Press).
27. NEWMAN SP, STEED KP, HOOPER G, JONES JI, UPCHURCH FC: Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler. Respir. Med. (1999) 93(6):424-431.
28. ELVECROG J: Metered dose inhalers in a CFC-free future. Pharm. Tech. Eur. (1997) 9:52-55.
29. DOLOVICH MB, AHRENS RC, HESS DR et al.: Device selection and outcomes of aerosol therapy. Chest (2005) 127(1):335-371.
30. NEWMAN SP, WEISZ AW, TALAEE N, CLARKE SW: Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 46(10):712-716.
31. PEDERSON S, FROST L, ARNFRED T: Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy (1986) 46:118-124.
32. CROMPTON GK: Problems patients have using pressurized aerosol inhalers. Eur. J. Respir. Dis. (1982) 63(Suppl. 119):101-104.
33. COADY TJ, DAVIES HJ, BARNES P: Evaluation of a breath actuated pressurized aerosol. Clin. Allergy (1976) 6(1):1-6.
34. KELLOWAY JS, KOCHEVAR JW, SVEUM RJ, HAHN MA: Evaluation of the Autohaler actuator: the effect of written patient instructions on correct use. J. Asthma (1993) 30(5):373-379.
35. BACON RJ, MCDERMENT I, BELL J: A new breath operated actuator. Proceedings of Respiratory Drug Delivery VIII. Tucson, AZ, USA (2002) 2:403-406.
36. PRICE D, THOMAS M, MITCHELL G, NIZIOL C, FEATHERSTONE R: Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device. Respir. Med. (2003) 97(1):12-19.
37. CHAPMAN KR, LOVE L, BRUBAKER H: A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest (1993) 104(5):1332-1336.
38. CLARK AR: Metered atomization for respiratory drug delivery. PhD Thesis. Loughborough University of Technology (1991).
39. DUNBAR CA, WATKINS AP, MILLER JF: An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J. Aerosol Med. (1997) 10(4):351-368.
40. GANDERTON D, LEWIS D, DAVIES R, MEAKIN B, BRAMBILLA G, CHURCH T: Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers. Respir. Med. (2002) 96(Suppl. D):S3-S8.
41. CLARK AR: MDIs: physics of aerosol formation. J. Aerosol Med. (1996) 9(Suppl. 1):S19-S26.
42. DAVIES RJ, LEWIS DA, GANDERTON D, MFAKIN BJ, BRAMBILLA G, MURPHY SD, NICHOLLS TR: Velocity profiling of a new HFA budesonide pMDI. Proceedings of Respiratory Drug Delivery VIII. Tucson, AZ, USA (2002) 2:759-762.
43. STEIN SW, GABRIO BJ: Understanding throat deposition during cascade impactor testing. Proceedings of Respiratory Drug Delivery VII. Tarpon Springs, FL, USA (2000) 2:287-290.
44. STEIN SW, MYRDAL PB: A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J. Pharm. Sci. (2004) 93(8):2158-2175.
45. MEAKIN BJ, GANDERTON D, PANZA I, VENTURA P: Drug delivery from pressurised metered dose inhalers (pMDIs) containing BDP using the Chiesi Jet actuator. Proceedings of Respiratory Drug Delivery V. Phoenix, AZ, USA (1996):370-373.
46. LEWIS DA, MEAKIN BJ, BRAMBILLA G: Theory and practice with solution systems. Proceedings of Respiratory Drug Delivery IX. Palm Desert, CA, USA (2004) 1:109-115.
47. VERSTEEG HK, HARGRAVE G, HARRINGTON L, SHRUBB I, HODSON D: The use of computational fluid dynamics (CFD) to predict pMDI air flows and aerosol plume formation. Proceedings of Respiratory Drug Delivery VII. Tarpon Springs, FL, USA (2000) 2:257-264.
48. FINLAY WH: The Mechanics of Inhaled Pharmaceutical Aerosols. Academic Press, San Diego, CA, USA (2001).
49. BRAMBILLA G, DAVIES RJ, LEWIS DA, GEORGE SC, GANDERTON D, MEAKIN BJ: Formulation of oestrogens as HFA solution pMDIs. J. Aerosol Med. (2003) 16(2):211.
50. TANENBAUM MF, BRAMANTE T, SHU F, ANGELA, PARK J: Minimization of actuator (mouthpiece) clogging for solution inhalation aerosol products. Proceedings of Respiratory Drug Delivery VI. Hilton Head, SC, USA (1998) 2:429-434.
51. SMYTH H, BRACE G, BARBOUR T, GALLION J, GROVE J, HICKEY AJ: Spray pattern analysis for metered dose inhalers: effect of actuator design. Pharm. Res. (2006) 23(7):1591-1596.
52. MEAKIN BJ, LEWIS DA, GANDERTON D et al.: Effects of actuator orifice diameter on beclomethasone dipropionate delivery from a pMDI HFA solution formulation. Proceedings of Respiratory Drug Delivery VI. Hilton Head, SC, USA (1998) 2:363-366.
53. MEAKIN BJ, LEWIS DA, CHURCH TK, GANDERTON D, RICHARDS J, BRAMBILLA G: A comparative formoterol HFA pMDI delivery performance from an integral device. Proceedings of Respiratory Drug Delivery IX. Palm Desert, CA, USA (2004) 2:845-848.
54. MEAKIN BJ, LEWIS DA, CHURCH TK, GANDERTON D, BRAMBILLA G: Budesonide 200 HFA Modulite delivery from the Chiesi Jet. Drug Deliv. Lungs (2003) 14:126-128.
55. MITCHELL JP, NAGEL MW: Spacer and holding chamber testing in-vitro: a critical analysis with examples. Proceedings of Respiratory Drug Delivery VII. Tarpon Springs, FL, USA (2000) 1:265-274.
56. KWOK P, CHAN HK: Electrostatic charges of metered dose inhaler aerosols sampled from plastic spacers. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 1:121-132.
57. KEIL JC, KOTIAN R, PEART J: Using and interpreting aerosol electrostatic data from the electrical low pressure impactor. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 1:267-278.
58. KOTIAN R, PEART J: Influence of formulation components on inherent electrostatic properties of HFA propelled solution pMDIs. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 3:947-950.
59. PEART J: Influence of static charge on dynamic performance of inhaled drug products. Proceedings of Academy of Pharmaceutical Sciences Inhalation. (2007) Bath, UK.
60. BRAMBILLA G, GANDERTON D, LEWIS DA, MEAKIN BJ, GARZIA R: The modulation of clouds generated by pMDIs. J. Aerosol Med. (1999) 12:119.
61. MEAKIN BJ, LEWIS DA, GANDERTON D, BRAMBILLA G: Countering challenges posed by mimicry of CFC performance using HFA systems. Proceedings of Respiratory Drug Delivery VII. Tarpon Springs, FL, USA (2000) 1:99-107.
62. BERRY J, KLINE LC, SHERWOOD JK et al.: Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhaler. Drug Dev. Ind. Pharm. (2004) 30(7):705-714.
63. BERRY J, HEIMBECHER S, HART JL, SEQUEIRA J: Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler. Drug Dev. Ind. Pharm. (2003) 29(8):865-876.
64. SMYTH HD: The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv. Drug Deliv. Rev. (2003) 55(7):807-828.
65. WILLIAMS RO, LIU J, KOLENG JJ: Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a. Pharm. Res. (1997) 14(4):438-443.
66. BERRY J, KLINE L, NAINI V, CHAUDHRY S, HART J, SEQUEIRA J: Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler. Drug Dev. Ind. Pharm. (2004) 30(3):267-275.
67. BERRY J, KLINE LC, HART JL, SEQUEIRA J: Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227. Drug Dev. Ind. Pharm. (2003) 29(6):631-639.
68. GUPTA A, STEIN SW, MYRDAL PB: Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J. Aerosol Med. (2003) 16(2):167-174.
69. STEIN SW, MYRDAL PB, GABRIO BJ, OBEREIT D, BECK TJ: Evaluation of a new aerodynamic particle sizer spectrometer for size distribution measurements of solution metered dose inhalers. J. Aerosol Med. (2003) 16(2):107-119.
70. DOMNICK J, DURST F: Measurement of bubble size, velocity and concentration in flashing flow behind a sudden constriction. Int. J. Multiphase Flow (1995) 21(6):1047-1062.
71. BRAMBILLA G, GANDERTON D, GARZIA R, LEWIS D, MEAKIN B, VENTURA P: Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int. J. Pharm. (1999) 186(1):53-61.
72. HOCHRAINER D, HOLZ H, KREHER C, SCAFFIDI L, SPALLEK M, WACHTEL H: Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist® inhaler and pressurized metered dose inhalers. J. Aerosol Med. (2005) 18(3):273-282.
73. NEWMAN SP, STEED KP, HOOPER G, JONES JI, UPCHURCH FC: Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler. Respir. Med. (1999) 93(6):424-431.
74. GABRIO BJ, STEIN SW, VELASQUEZ DJ: A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int. J. Pharm. (1999) 186(1):3-12.
75. ROSS DL, GABRIO BJ: Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. Int. J. Pharm. (1999) 12(3):151-160.
76. BRAMBILLA G, CHURCH T, KEEBLE C, LEWIS D, MEAKIN B: The determination of the plume temperature for budesonide HFA metered dose inhalers. Proceedings of Drug Delivery to the Lungs 17. Edinburgh, Scotland, UK (2006):94-97.
77. BRAMBILLA G, CHURCH TK, LEWIS DA, MEAKIN BJ: Control of plume temperature emitted from metered dose inhalers. (In Press).
78. WILBY M, PURKINS G: The 3M™ integrated dose by dose counter for pMDIs. Proceedings of Drug Delivery to the Lungs 17. Edinburgh, Scotland, UK (2006):288-291.
79. BRADSHAW DR: Developing dose counters: an appraisal based on regulator, pharma, and user needs. Proceedings of Respiratory Drug Delivery X. Boca Raton, FL, USA (2006) 1:121-132.
80. CAIN WT, OPPENHEIMER JJ: The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devices. Ann. Allergy Asthma Immunol. (2001) 87(5):417-419.
81. HOLT S, HOLT A, WEATHERALL M, MASOLI M, BEASLEY R: Metered dose inhalers: a need for dose counters. Respirology (2005) 10(1):105-106.
82. JULIUS SM, SHERMAN JM, HENDELES L: Accuracy of three electronic monitors for metered-dose inhalers. Chest (2002) 121(3):871-876.
83. O'CONNOR SL, BENDER BG, GAVIN-DEVITT LA: Measuring adherence with the Doser CT in children with asthma. J. Asthma (2004) 41(6):663-670.
84. APTER AJ, TOR M, FELDMAN HI: Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers. Ann. Allergy Asthma Immunol. (2001) 86(4):421-424.
85. FARR SJ, ROWE AM, RUBSAMEN R, TAYLOR G: Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax (1995) 50(6):639-644.
86. BRAMBILLA G, BERRILL S, DAVIES RJ et al.: Formulation of leuprolide as a HFA solution pMDI. J. Aerosol Med. (2003) 16(2):209.
87. BRAMBILLA G, DAVIES RJ, LEWIS DA, GEORGE SC, GANDERTON D, MEAKIN BJ: Formulation of an analogue of apomorphine as an HFA solution pMDIs. J. Aerosol Med. (2003) 16(2):209.
88. SMYTH HD: Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. (2005) 2(1):53-74.
89. RAM FS: Clinical efficacy of inhaler devices containing β(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials. Am. J. Respir. Med. (2003) 2(4):349-365.
90. NOYMER P, SCHUSTER, J, HOLST, P et al.: AERx®-Essence™: efficiency and breath control without electronics. Proceedings of Respiratory Drug Delivery IX. Palm Desert, CA, USA (2004) 1:255-262.